Insulin Pumps Market

The latest report by IMARC Group, titled “Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the global insulin pumps market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

Insulin Pumps Industry Growth Analysis & Future Forecast:

The global insulin pumps market size reached a value of US$ 4.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2027, exhibiting at a CAGR of 6.5% during 2022-2027.

Insulin pumps are medical devices used for delivering a controlled dose of insulin at regular intervals to manage the blood sugar levels of the patient. The pump operates with a needle and catheter through which insulin is injected directly into the fat tissue. Some of the commonly used variants include tethered, patch, implanted and closed-loop insulin pumps. These pumps are widely utilized for the treatment of type 1 and type 2 diabetes. They cause minimal pain and discomfort to the patient and can be self-administered. As a result, insulin pumps are extensively used across hospitals and ambulatory and dialysis centers.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Insulin Pumps Market Trends:

The global insulin pumps market is primarily being driven by the increasing prevalence of obesity and diabetes among the masses. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Various technological advancements, such as the launch of self-adjustable insulin pump systems that are compatible with smartphone applications, are favoring the market growth.

These devices can be used by patients at home for regular monitoring of glucose levels, notifications and dosage alerts. Other factors, including the increasing health consciousness among the masses, along with extensive improvements in medical infrastructure, are creating a positive outlook for the market.

Competitive Landscape:                                

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Animus Corp.
  • Medtronics Inc.
  • Insulet Corp.
  • Roche Diagnostics
  • Cellnovo Ltd.
  • Asante
  • Nipro Diagnostic Inc.
  • Tandem Diabetes Care Inc.
  • Sooil Development Co. Ltd.
  • Ypsomed

Key Market Segmentation Breakup by:

Product Type:

  • Insulin Pumps
    • Tethered Pumps
    • Disposable/Patch Insulin Pumps
  • Insulin Pump Supplies and Accessories
    • Infusion Set Insertion Devices
    • Insulin Reservoirs/Cartridges

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics/ Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Author

%d bloggers like this: